Arcutis Biotherapeutics, Inc. - Common stock (ARQT) earnings
ARQT earnings moved a median of -0.84% by the close. Quarterly and annual ARQT reports and results, each read against the price at its own news timestamp. Back to the ARQT overview →
32 measured ARQT earnings events.
Where these ARQT earnings landedvs 32 measured ARQT earnings reactions
| Middle 50% of ARQT earnings reactions | -7.61% to +1.04% |
|---|---|
| Median reaction (to close) | -0.84% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 ARQT earnings events with a measured close landed between -7.61% and +1.04%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update | Press release | -6.44% | -8.77% | |
| Form 10-Q Arcutis Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | -6.44% | -8.77% | |
| Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026 | Press release | -1.24% | -0.18% | |
| Arcutis Announces First Quarter 2026 Financial Results and Provides Business Update | Press release | +0.72% | -9.46% | |
| Form 10-Q Arcutis Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.72% | -9.46% | |
| Arcutis to Report First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026 | Press release | -0.37% | -1.51% | |
| Form 10-K Arcutis Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | -6.97% | +3.18% | |
| Arcutis Outlines Strategy for Driving Sustainable Growth and Announces Third Quarter 2025 Financial Results | Press release | -1.60% | +10.89% | |
| Form 10-Q Arcutis Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.60% | +10.89% | |
| Arcutis Biotherapeutics to Host Virtual Investor Day and Report Third Quarter 2025 Financial Results on October 28, 2025 | Press release | +0.64% | -0.11% | |
| Arcutis Announces Second Quarter 2025 Financial Results and Provides Business Update | Press release | -8.36% | -13.21% | |
| Form 10-Q Arcutis Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | -8.36% | -13.21% | |
| Arcutis to Report Second Quarter 2025 Financial Results and Host Conference Call on August 6, 2025 | Press release | +0.88% | +1.28% | |
| Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update | Press release | -2.73% | -3.79% | |
| Form 10-Q Arcutis Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.73% | -3.79% | |
| Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 | Press release | +1.93% | +0.39% | |
| Form 10-K Arcutis Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | -8.48% | -4.55% | |
| Arcutis Announces Third Quarter 2024 Financial Results and Provides Business Update | Press release | -2.91% | +0.97% | |
| Form 10-Q Arcutis Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.91% | +0.97% | |
| Arcutis to Report Third Quarter 2024 Financial Results and Participate in an Upcoming Investor Conference | Press release | -1.20% | +0.84% | |
| Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update | Press release | -7.88% | -7.61% | |
| CORRECTION – Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update | Press release | -7.88% | -7.61% | |
| Form 10-Q Arcutis Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | -7.88% | -7.61% | |
| Arcutis to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024 | Press release | +0.00% | +1.87% | |
| Form 10-Q/A Arcutis Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.10% | +3.70% | |
| Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update | Press release | -4.29% | -1.81% | |
| Form 10-Q Arcutis Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | -4.29% | -1.81% | |
| Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 | Press release | -0.81% | -4.26% | |
| Form 10-K Arcutis Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | +4.81% | +1.24% | |
| Arcutis Announces Third Quarter 2023 Financial Results and Provides Business Update | Press release | +0.41% | +0.83% | |
| Form 10-Q Arcutis Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.41% | +0.83% | |
| Arcutis to Report Third Quarter 2023 Financial Results | Press release | +0.87% | +5.33% |
Keep exploring
More ARQT: analyst actions → · SEC filings → · ARQT overview →